KDM1A and cancer: Thus, the pharmacological inhibition of LSD1 may be a promising anti-cancer strategy, leading to reduced tumor growth and spread by modulating oncogenic signaling pathways responsible for the regulation of cell proliferation, migration, and apoptosis.